Search research articles
Contact Us
Filters
Showing results (161-170 of 522) with videos related to
Page
of 53
Sort By:
Expert Opinion on Drug Safety
|
November 7, 2025
The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis
Karolina Hoffmann, Michał Michalak, Manfredi Rizzo, et al.
Current Opinion in Pharmacology
|
May 13, 2026
The neuro-metabolic epidemic and the CB1R paradox
Francesca Vaccaro, Ginevra Malta, Manfredi Rizzo, et al.
Frontiers in Clinical Diabetes and Healthcare
|
November 17, 2025
Ferroptosis and pyroptosis in diabetes mellitus: emerging therapeutic potential of GLP-1 receptor agonists
Theodoros Panou, Evanthia Gouveri, Manfredi Rizzo, et al.
Expert Opinion on Pharmacotherapy
|
June 15, 2017
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy
Manfredi Rizzo, Dragana Nikolic, Francesco Di Pace, et al.
Expert Opinion on Drug Safety
|
February 21, 2022
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections
Ali A Rizvi, Ales Linhart, Michal Vrablik, et al.
Journal of Neurogastroenterology and Motility
|
October 10, 2023
The Effect of Curcumin on the Gut-Brain Axis: Therapeutic Implications
Ayesheh Enayati, Aida Soghi, Alexandra E Butler, et al.
Expert Opinion on Pharmacotherapy
|
December 7, 2018
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children
Dragana Nikolic, Andreea Corina, Peter P Toth, et al.
Frontiers in Nutrition
|
February 6, 2023
Editorial: Diet-microbe-host interactions in metabolic syndrome
Gratiela Gradisteanu Pircalabioru, Manfredi Rizzo, Anca Pantea Stoian, et al.
Pragmatic and Observational Research
|
August 12, 2024
Therapeutic Advances in Obesity: How Real-World Evidence Impacts Affordability Beyond Standard of Care
Dimitrios Patoulias, Theocharis Koufakis, Ieva Ruža, et al.
Journal of Diabetes and Its Complications
|
January 9, 2023
Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature
Ana Realista Pedrosa, Diana Cruz Martins, Manfredi Rizzo, et al.
Page
of 53
Search research articles
Search
Showing results (161-170 of 522) with videos related to
Sort By:
Page
of 53
Expert Opinion on Drug Safety
|
November 7, 2025
The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis
Karolina Hoffmann, Michał Michalak, Manfredi Rizzo, et al.
Current Opinion in Pharmacology
|
May 13, 2026
The neuro-metabolic epidemic and the CB1R paradox
Francesca Vaccaro, Ginevra Malta, Manfredi Rizzo, et al.
Frontiers in Clinical Diabetes and Healthcare
|
November 17, 2025
Ferroptosis and pyroptosis in diabetes mellitus: emerging therapeutic potential of GLP-1 receptor agonists
Theodoros Panou, Evanthia Gouveri, Manfredi Rizzo, et al.
Expert Opinion on Pharmacotherapy
|
June 15, 2017
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy
Manfredi Rizzo, Dragana Nikolic, Francesco Di Pace, et al.
Expert Opinion on Drug Safety
|
February 21, 2022
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections
Ali A Rizvi, Ales Linhart, Michal Vrablik, et al.
Journal of Neurogastroenterology and Motility
|
October 10, 2023
The Effect of Curcumin on the Gut-Brain Axis: Therapeutic Implications
Ayesheh Enayati, Aida Soghi, Alexandra E Butler, et al.
Expert Opinion on Pharmacotherapy
|
December 7, 2018
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children
Dragana Nikolic, Andreea Corina, Peter P Toth, et al.
Frontiers in Nutrition
|
February 6, 2023
Editorial: Diet-microbe-host interactions in metabolic syndrome
Gratiela Gradisteanu Pircalabioru, Manfredi Rizzo, Anca Pantea Stoian, et al.
Pragmatic and Observational Research
|
August 12, 2024
Therapeutic Advances in Obesity: How Real-World Evidence Impacts Affordability Beyond Standard of Care
Dimitrios Patoulias, Theocharis Koufakis, Ieva Ruža, et al.
Journal of Diabetes and Its Complications
|
January 9, 2023
Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature
Ana Realista Pedrosa, Diana Cruz Martins, Manfredi Rizzo, et al.
Page
of 53